ROSSARI BIOTECH Showing Change in Price Structure

10 Eyl

ROSSARI


....................................................................................................................
....................................................................................................................
....................................................................................................................

Update on the expansion projects at Dahej Facilities

....................................................................................................................

• In the Q2FY24 the Company had announced an expansion of its facility at Dahej by adding up
20,000 MTPA capacity for products related to HPPC in the specialty chemical space, as well as for producing ingredients for its subsidiary companies.

Also, to cater to the growing
demand in agro chemicals, home and personal care, oil & gas and the pharma sector, the
Company had further announced expansion of the Ethoxylation capacity by 30,000 MTPA at
the Dahej facility of Unitop Chemicals Private Limited.


• Work on both these projects are progressing as planned. Commissioning is expected to
happen, in a phased manner in the current year




....................................................................................................................
....................................................................................................................
....................................................................................................................

• Consistent growth trajectory over the past three years, driven by both organic and inorganic growth strategies

• While near-term investments and strategic initiatives have led to a moderation in ROCE and ROE, the balance sheet position
remains strong.

The Company is confident of reporting improved return metrics in the future as these investments start yielding
results